galactose has been researched along with cucurbitacin b in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, D; Deng, Y; Gu, J; Hu, H; Sun, J; Wang, W; Zhao, X | 1 |
1 other study(ies) available for galactose and cucurbitacin b
Article | Year |
---|---|
Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Cell Line, Tumor; Cell Survival; Drug Compounding; Drug Delivery Systems; Galactose; Indicators and Reagents; Injections, Intravenous; Lipids; Liver; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Protective Agents; Rats; Rats, Wistar; Spectrophotometry, Ultraviolet; Tissue Distribution; Triterpenes | 2010 |